The gut microbiota plays critical roles in development of obese-related metabolic diseases
such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and insulin …

The incidence of obesity and its related conditions, including non-alcoholic fatty liver
disease (NAFLD), has dramatically increased in all age groups worldwide. Given the health …

The aim of this study was to investigate the effects of probiotic yogurt consumption on some
metabolic factors in nonalcoholic fatty liver disease (NAFLD) patients. This double-blind …

Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of health
problems in Western (industrialized) countries. Moreover, the incidence of infantile NAFLD is …

Although gut diseases such as inflammatory bowel disease, mucositis and the alimentary
cancers share similar pathogenetic features, further investigation is required into new …

Background: Non-alcoholic steatohepatitis (NASH) is a clinicopathological entity that is
being recognized more frequently in recent years. This study aimed to evaluate the effects of …

Intestinal barrier defects lead to “leaky gut syndrome”, defined as an increase in intestinal
permeability that allows the passage of luminal content into intestinal tissue and the …

Aim: Despite extensive ongoing research, there is scarcity of widely accepted therapeutic
options for the treatment of nonalcoholic fatty liver disease (NAFLD). Probiotics are a …

Oxidative stress and inflammation are well-known triggers of NAFLD onset and progression.
The aim of this study is to compare the potential benefits of a viable probiotic (Lactobacillus …

Results Probiotics, as biological factors, control the gut microbiota and result in its
progression. It is in this sense that they are suggestive of a new and a natural way of …